Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Actelion Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
Enamine Expands Agreement with Actelion 14
SynAging Extends Agreement with Actelion Pharma 15
Handok Enters into Agreement with Actelion Pharmaceuticals 16
Actelion Forms Joint Venture with Max Planck Society 17
ZoBio Enters Into Drug Discovery Agreement With Actelion Pharma For Fragment Ligands 18
Licensing Agreements 19
Actelion Enters into Licensing Agreement with ReveraGen BioPharma 19
GBC-Atrial Enters into Licensing Agreement with Actelion Pharma 20
Kythera Biopharma Enters into Licensing Agreement with Actelion Pharma 21
Auxilium Pharma Enters Into Licensing Agreement With Actelion Pharma For XIAFLEX 22
Theratechnologies Enters Into Licensing Agreement With Actelion Pharma For Lipodystrophy Drug 24
Equity Offering 25
Actelion Spun Out its Drug Discovery and Early Clinical Pipeline Business 25
Asset Transactions 26
Helsinn Healthcare to Acquire Rights of Valchlor/Ledaga from Actelion Pharma 26
Acquisition 27
Johnson & Johnson Acquires Actelion for USD30 Billion 27
Actelion Plans to Acquire ZS Pharma 29
Actelion Rejects Acquisition Offer from Shire 30
Tetraphase Pharma May Sell Itself 31
Actelion Completes Acquisition Of Ceptaris Therapeutics For US$250 Million 32
Actelion Pharmaceuticals Ltd – Key Competitors 34
Actelion Pharmaceuticals Ltd – Key Employees 35
Actelion Pharmaceuticals Ltd – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 40
Financial Announcements 40
Feb 14, 2017: Actelion announces excellent financial results for 2016 40
Corporate Communications 44
Aug 06, 2018: Alzheon appoints former IVAX president, Neil Flanzraich, JD, as vice chairman of board of directors 44
Jun 09, 2017: Publication of Idorsia’s prospectus relating to the listing of Idorsia on SIX Swiss Exchange 45
May 15, 2017: Actelion announces changes to its executive team upon completion of the transaction with Johnson & Johnson 47
Other Significant Developments 48
May 22, 2017: Actelion provides an update on the progress towards launching Idorsia – Key results for pipeline assets to be developed by Idorsia 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actelion Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Actelion Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Enamine Expands Agreement with Actelion 14
SynAging Extends Agreement with Actelion Pharma 15
Handok Enters into Agreement with Actelion Pharmaceuticals 16
Actelion Forms Joint Venture with Max Planck Society 17
ZoBio Enters Into Drug Discovery Agreement With Actelion Pharma For Fragment Ligands 18
Actelion Enters into Licensing Agreement with ReveraGen BioPharma 19
GBC-Atrial Enters into Licensing Agreement with Actelion Pharma 20
Kythera Biopharma Enters into Licensing Agreement with Actelion Pharma 21
Auxilium Pharma Enters Into Licensing Agreement With Actelion Pharma For XIAFLEX 22
Theratechnologies Enters Into Licensing Agreement With Actelion Pharma For Lipodystrophy Drug 24
Actelion Spun Out its Drug Discovery and Early Clinical Pipeline Business 25
Helsinn Healthcare to Acquire Rights of Valchlor/Ledaga from Actelion Pharma 26
Johnson & Johnson Acquires Actelion for USD30 Billion 27
Actelion Plans to Acquire ZS Pharma 29
Actelion Rejects Acquisition Offer from Shire 30
Tetraphase Pharma May Sell Itself 31
Actelion Completes Acquisition Of Ceptaris Therapeutics For US$250 Million 32
Actelion Pharmaceuticals Ltd, Key Competitors 34
Actelion Pharmaceuticals Ltd, Key Employees 35
Actelion Pharmaceuticals Ltd, Subsidiaries 36
List of Figures
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Actelion Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 11